medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Number 4

<< Back Next >>

Ann Hepatol 2012; 11 (4)

The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico

Méndez-Sánchez N

Language: English
References: 13
Page: 550-551
PDF size: 55.66 Kb.


Text Extraction

Hepatitis C virus is one of the most common causes of chronic liver disease and one of the principal indications for liver transplantation. Its prevalence and worldwide incidence varies, although there may be some similarities between different regions. Worldwide, the prevalence has been estimated to be approximately, 2.35% or 160 million infected people.


REFERENCES

  1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-15.

  2. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, et al. Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Sal Pub Mex 2007; 49: 395-403.

  3. Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9(Suppl.): 27-9.

  4. Censo de Población y Vivienda de México 2010. Available from: www.inegi.org.mx

  5. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120: 749-62.

  6. Thomas DL. Advances in the treatment of hepatitis C virus infection. Top Antivir Med 2012; 20: 5-10.

  7. Poordad F, McCone J Jr., Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-206.

  8. Jacobson IM, McHutchinson, JG, Dusheiko G, et al. Teleprevir in combination with Peginterferon and Ribavirin in treatment-naïve patients with genotype 1 chronic hepatitis C. N Engl J Med 2011; 364: 2405-16.

  9. Bacon BR, Gordon SC, Lawitz E, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-17.

  10. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754-8.

  11. Lee CM, Lu SN, Hung CH, Tung WC, Wang JH, Tung HD, et al. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans R Soc Trop Med Hyg 2006; 100: 767-74.

  12. U.S. & World Population Clocks. http://www.census.gov/ main/www/popclock.html. [Accessed April 17,2012].

  13. Cammà C, Petta S, Enea M, Bruno R, Bronte F, Capursi V, Cicchetti A, Colombo GL, et al; on behalf of the WEF Study Group. Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C. Hepatology 2012. Doi: 10.1002/hep.25734 [Epub ahead of print].




2020     |     www.medigraphic.com